The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells
Work
Year: 2014
Type: article
Abstract: : Glioblastoma is one of the most common malignant tumors in the nervous system in both adult and pediatric patients. Studies suggest that abnormal activation of receptor tyrosine kinases contributes ... more
Source: OncoTargets and Therapy
Cites: 41
Cited by: 25
Related to: 10
FWCI: 0.885
Citation percentile (by year/subfield): 86.55
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal No poverty
Open Access status: gold
APC paid (est): $2,836